Artificial intelligence and the impact of multiomics on the reporting of case reports.

The integration of artificial intelligence (AI) and multiomics has transformed clinical and life sciences, enabling precision medicine and redefining disease understanding. Standardizing data reporting and addressing challenges in ethics and data quality will unlock their full potential.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Scientific publications grew significantly from 2.1 million in 2012 to 3.3 million in 2022, with AI research tripling during this period.
• 2 Multiomics fields, including genomics and proteomics, also advanced, exemplified by the Human Proteome Project achieving a 90% complete blueprint by 2021.
• 3 This growth highlights opportunities and challenges in integrating AI and multiomics into clinical reporting.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: